Epidemiological Aspects of Cognitive and Socio-Professional Integration in Schizophrenia.

Schizophrenia is one of the major psychiatric disorders with global impairment of cognition, emotional status and personality destruction having a major medical, social and economic impact worldwide. In this paper, we evaluated the correlation of disease progression with cognitive deficit, socio-professional and family disjunction using the MMSE (Mini Mental State Examination) and GAFS (Global Assessment of Functioning Scale) scales on a group of 191 schizophrenic patients admitted to the Psychiatric Clinic II Craiova during 2017. The fact that both scales show reduced values in patients with schizophrenia reveals a significant alteration in the quality of life of patients with this pathology having major implications on the individuals and on the community.

Therapeutic Particularities with Depot Medications in Schizophrenia.

Schizophrenia is a neurodegenerative disease with personality degradation, changes in behavior, cognition, affective disorder and reduced socio-professional insertion. Early diagnosis is necessary and maintenance is ensured by antipsychotic treatment and for non-compliant patients there is an alternative to depot medication that greatly improves therapeutic adherence. The study presents the case of a 43-year-old patient diagnosed with paranoid schizophrenia using the Diagnostic and Statistical Manual of Mental Disorders V-TR criteria that showed a favorable evolution under depot treatment.